πŸ‡ΊπŸ‡Έ FDA
Patent

US 7635474

VEGF-binding fusion proteins

granted A61KA61K38/00A61P

Quick answer

US patent 7635474 (VEGF-binding fusion proteins) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00, A61P, A61P27/00, A61P27/02